NEXI Company Profile and Key Details

Q: Who are the executives of NEXI?

Ms. Kristi Jones R.Ph.Chief Executive Officer, Pres & DirectorMr. John Trainer M.B.A.Chief Financial OfficerDr. Jeffrey S. Weber M.D., Ph.D.Chief Scientific Advisor, Co-Chairman of Scientific Advisory Board and Member of AI & ID SABMr. Karen HaslbeckHead of HRDr. Robert Douglas Knight M.D.Chief Medical OfficerDr. Daniel P. BednarikSenior Vice President of Molecular Engineering & Protein DesignDr. Jerome Bernard Zeldis M.D., Ph.D.ConsultantDr. Jack A. Ragheb M.D., Ph.D.Senior Vice President of Translational ScienceMr. Chad RubinSenior Vice President of Corporation AffairsDr. Mathias Oelke Ph.D.Chief Scientific OfficerMr. Matthew SchillerHead of Bus. Devel.

NASDAQ : NEXI

NexImmune

$0.00

At Close 4:00 PM

63.52

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

NexImmune, Inc. (NEXI) stock remained unchanged at $0.00 a share on OTC. The stock opened at $0.00, fluctuating between $0.00 to $0.00 during the session.

Stock Snapshot

0.0001

Prev. Close

139

Market Cap

0.0001

Day Low

N/A

P/E Ratio

-21.10534

EPS (TTM)

-29.52

Cash Flow per Share

Open

1.39M

Number of Shares

0.0002

Day High

84.49%

Free Float in %

3.29

Book Value

100

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 19, 2026	0.00	0.00	0.00	0.00	178
Aug 14, 2026	0.00	0.00	0.00	0.00	132
Jul 09, 2026	0.00	0.00	0.00	0.00	612
Jun 25, 2026	0.00	0.00	0.00	0.00	842
Jun 24, 2026	0.00	0.00	0.00	0.00	5.77K
Jun 18, 2026	0.00	0.00	0.00	0.00	9.28K
Jun 12, 2026	0.00	0.00	0.00	0.00	186
Jun 05, 2026	0.00	0.00	0.00	0.00	108
May 29, 2026	0.00	0.00	0.00	0.00	400
May 27, 2026	0.00	0.00	0.00	0.00	1.28K
May 26, 2026	0.00	0.00	0.00	0.00	159
May 21, 2026	0.00	0.00	0.00	0.00	1.83K
May 14, 2026	0.00	0.00	0.00	0.00	540
May 08, 2026	0.00	0.00	0.00	0.00	2.34K
Apr 28, 2026	0.00	0.00	0.00	0.00	640
Apr 27, 2026	0.00	0.00	0.00	0.00	176
Apr 23, 2026	0.00	0.00	0.00	0.00	1K
Apr 21, 2026	0.00	0.00	0.00	0.00	595
Apr 02, 2026	0.00	0.00	0.00	0.00	192
Mar 23, 2026	0.00	0.00	0.00	0.00	303

Contact Details

Gaithersburg, MD 20877

United States

https://www.neximmune.com 301 825 9810

About Company

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a vivo directly injectable modality platform. The company’s product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It also provides NEXI-004 which is in preclinical stage for EBV related diseases. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

Stock Peers

LFLY

Leafly Holdings, Inc.$37.00 CHGCY

-0.1-0.63%

Chugai Pharmaceutical Co., Ltd.$15.76 BIOYF

-0.05-0.73%

BioSyent Inc.$6.80 CPHRF

-0.31-4.77%

Cipher Pharmaceuticals Inc.$6.19 NPPNY

-0.6-10.71%

Nippon Shinyaku Co., Ltd.$5.00 SYMQY

SymBio Pharmaceuticals Limited$1.21 NVACF

Nova Cannabis Inc.$0.87 ALBHF

Alibaba Health Information Technology Limited$0.42 CRRTF

-0.0005-0.16%

Crescita Therapeutics Inc.$0.32 BXPHF

Botanix Pharmaceuticals Limited$0.21

Frequently Asked Questions

What is the current NexImmune, Inc. (NEXI) stock price?

NexImmune, Inc. (OTC: NEXI) stock price is $0.00 in the last trading session. During the trading session, NEXI stock reached the peak price of $0.00 while $0.00 was the lowest point it dropped to. The percentage change in NEXI stock occurred in the recent session was 0% while the dollar amount for the price change in NEXI stock was $0.00.

NEXI's industry and sector of operation?

The OTC listed NEXI is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector. NexImmune, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NEXI?

Ms. Kristi Jones R.Ph.
Chief Executive Officer, Pres & Director
Mr. John Trainer M.B.A.
Chief Financial Officer
Dr. Jeffrey S. Weber M.D., Ph.D.
Chief Scientific Advisor, Co-Chairman of Scientific Advisory Board and Member of AI & ID SAB
Mr. Karen Haslbeck
Head of HR
Dr. Robert Douglas Knight M.D.
Chief Medical Officer
Dr. Daniel P. Bednarik
Senior Vice President of Molecular Engineering & Protein Design
Dr. Jerome Bernard Zeldis M.D., Ph.D.
Consultant
Dr. Jack A. Ragheb M.D., Ph.D.
Senior Vice President of Translational Science
Mr. Chad Rubin
Senior Vice President of Corporation Affairs
Dr. Mathias Oelke Ph.D.
Chief Scientific Officer
Mr. Matthew Schiller
Head of Bus. Devel.

How NEXI did perform over past 52-week?

NEXI's closing price is 0% higher than its 52-week low of $0.00 where as its distance from 52-week high of $1.01 is -99.99%.

How many employees does NEXI have?

Number of NEXI employees currently stands at 6.

Link for NEXI official website?

Official Website of NEXI is: https://www.neximmune.com

How do I contact NEXI?

NEXI could be contacted at phone 301 825 9810 and can also be accessed through its website. NEXI operates from 9119 Gaither Road, Gaithersburg, MD 20877, United States.

How many shares of NEXI are traded daily?

NEXI stock volume for the day was 100 shares. The average number of NEXI shares traded daily for last 3 months was 337.

What is the market cap of NEXI currently?

The market value of NEXI currently stands at $139.00 with its latest stock price at $0.00 and 1.39M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	6
Beta	4.06
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Pharmaceuticals

Employees	6
Beta	4.06
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Pharmaceuticals

NEXI Company Profile and Key Details

NexImmune

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Key Takeaways

Price Forecast & Outlook

Valuation Metrics